M. Gomathi, Nair Deepa, Aiswarya Muraleedharan, Shanmugavel Uma Maheswari, R. Thirumalaisamy, T. Selvankumar, Arunachalam Chinnathambi, Sulaiman Ali Alharbi
{"title":"新型给药材料:壳聚糖聚合物与羽扇豆植物化合物共轭,增强抗微生物和抗癌特性","authors":"M. Gomathi, Nair Deepa, Aiswarya Muraleedharan, Shanmugavel Uma Maheswari, R. Thirumalaisamy, T. Selvankumar, Arunachalam Chinnathambi, Sulaiman Ali Alharbi","doi":"10.1002/pat.6561","DOIUrl":null,"url":null,"abstract":"The current study aimed to investigate the drug delivery potential of chitosan‐conjugated <jats:italic>Spondias pinnata</jats:italic> phytocompounds for anticancer and antibacterial applications. The phytochemical composition of the aqueous extract of <jats:italic>S. pinnata</jats:italic> plant leaves revealed seven major compounds, including stearic acid, 2H‐Indol‐2‐one, beta amyrin, oleic acid, octadecanoic acid, 7‐hexadecenoic acid, and phytol. Additionally, five minor compounds were identified through GC–MS analysis. SEM analysis of chitosan‐conjugated <jats:italic>S. pinnata</jats:italic> phytocompounds revealed amorphous particles. This demonstrates the attainment of optimized larger crystallites, which differ in size and shape extensively. The antioxidant potential of both the chitosan‐conjugated <jats:italic>S. pinnata</jats:italic> phytocompounds and <jats:italic>S. pinnata</jats:italic> leaf extracts was evaluated via DPPH and ABTS assays, and the results revealed that the chitosan‐conjugated <jats:italic>S. pinnata</jats:italic> phytocompounds exhibited significant scavenging activity, with IC<jats:sup>50</jats:sup> values of 18.20 and 33.15 μg/mL, respectively. Chitosan‐conjugated <jats:italic>S. pinnata</jats:italic> phytocompounds also demonstrated antibacterial activity against four clinically significant infections, with zones of inhibition ranging from 16 ± 0.07, 19 ± 0.10, 17 ± 0.09, and 19 ± 0.11 mm against <jats:italic>Escherichia coli</jats:italic> (MTCC 452), <jats:italic>Salmonella typhi</jats:italic> (MTCC 733), <jats:italic>Klebsiella pneumonia</jats:italic> (MTCC 39), and <jats:italic>Pseudomonas aeruginosa</jats:italic> (MTCC 1688), respectively. Furthermore, the cytotoxicity of the chitosan‐conjugated <jats:italic>S. pinnata</jats:italic> phytocompounds was assessed against A549 lung cancer cells, and the results revealed a significant reduction in cell viability (33.85) at higher concentrations of 150 μg/mL. The IC<jats:sup>50</jats:sup> values of <jats:italic>S. pinnata</jats:italic> leaf extract (149.2 mg/mL) and chitosan‐conjugated <jats:italic>S. pinnata</jats:italic> (126.4 mg/mL) toward A549 lung cancer cells were recorded. Overall, the results of the present study highlight the therapeutic applications of chitosan‐conjugated <jats:italic>S. pinnata</jats:italic> phytocompounds, particularly in the context of their anticancer and antibacterial activities.","PeriodicalId":20382,"journal":{"name":"Polymers for Advanced Technologies","volume":null,"pages":null},"PeriodicalIF":3.1000,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Novel drug delivery materials: Chitosan polymers conjugated with Spondias pinnata phytocompounds for enhanced anti‐microbial and anti‐cancer properties\",\"authors\":\"M. Gomathi, Nair Deepa, Aiswarya Muraleedharan, Shanmugavel Uma Maheswari, R. Thirumalaisamy, T. Selvankumar, Arunachalam Chinnathambi, Sulaiman Ali Alharbi\",\"doi\":\"10.1002/pat.6561\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The current study aimed to investigate the drug delivery potential of chitosan‐conjugated <jats:italic>Spondias pinnata</jats:italic> phytocompounds for anticancer and antibacterial applications. The phytochemical composition of the aqueous extract of <jats:italic>S. pinnata</jats:italic> plant leaves revealed seven major compounds, including stearic acid, 2H‐Indol‐2‐one, beta amyrin, oleic acid, octadecanoic acid, 7‐hexadecenoic acid, and phytol. Additionally, five minor compounds were identified through GC–MS analysis. SEM analysis of chitosan‐conjugated <jats:italic>S. pinnata</jats:italic> phytocompounds revealed amorphous particles. This demonstrates the attainment of optimized larger crystallites, which differ in size and shape extensively. The antioxidant potential of both the chitosan‐conjugated <jats:italic>S. pinnata</jats:italic> phytocompounds and <jats:italic>S. pinnata</jats:italic> leaf extracts was evaluated via DPPH and ABTS assays, and the results revealed that the chitosan‐conjugated <jats:italic>S. pinnata</jats:italic> phytocompounds exhibited significant scavenging activity, with IC<jats:sup>50</jats:sup> values of 18.20 and 33.15 μg/mL, respectively. Chitosan‐conjugated <jats:italic>S. pinnata</jats:italic> phytocompounds also demonstrated antibacterial activity against four clinically significant infections, with zones of inhibition ranging from 16 ± 0.07, 19 ± 0.10, 17 ± 0.09, and 19 ± 0.11 mm against <jats:italic>Escherichia coli</jats:italic> (MTCC 452), <jats:italic>Salmonella typhi</jats:italic> (MTCC 733), <jats:italic>Klebsiella pneumonia</jats:italic> (MTCC 39), and <jats:italic>Pseudomonas aeruginosa</jats:italic> (MTCC 1688), respectively. Furthermore, the cytotoxicity of the chitosan‐conjugated <jats:italic>S. pinnata</jats:italic> phytocompounds was assessed against A549 lung cancer cells, and the results revealed a significant reduction in cell viability (33.85) at higher concentrations of 150 μg/mL. The IC<jats:sup>50</jats:sup> values of <jats:italic>S. pinnata</jats:italic> leaf extract (149.2 mg/mL) and chitosan‐conjugated <jats:italic>S. pinnata</jats:italic> (126.4 mg/mL) toward A549 lung cancer cells were recorded. Overall, the results of the present study highlight the therapeutic applications of chitosan‐conjugated <jats:italic>S. pinnata</jats:italic> phytocompounds, particularly in the context of their anticancer and antibacterial activities.\",\"PeriodicalId\":20382,\"journal\":{\"name\":\"Polymers for Advanced Technologies\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2024-09-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Polymers for Advanced Technologies\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.1002/pat.6561\",\"RegionNum\":4,\"RegionCategory\":\"工程技术\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"POLYMER SCIENCE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Polymers for Advanced Technologies","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1002/pat.6561","RegionNum":4,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"POLYMER SCIENCE","Score":null,"Total":0}
Novel drug delivery materials: Chitosan polymers conjugated with Spondias pinnata phytocompounds for enhanced anti‐microbial and anti‐cancer properties
The current study aimed to investigate the drug delivery potential of chitosan‐conjugated Spondias pinnata phytocompounds for anticancer and antibacterial applications. The phytochemical composition of the aqueous extract of S. pinnata plant leaves revealed seven major compounds, including stearic acid, 2H‐Indol‐2‐one, beta amyrin, oleic acid, octadecanoic acid, 7‐hexadecenoic acid, and phytol. Additionally, five minor compounds were identified through GC–MS analysis. SEM analysis of chitosan‐conjugated S. pinnata phytocompounds revealed amorphous particles. This demonstrates the attainment of optimized larger crystallites, which differ in size and shape extensively. The antioxidant potential of both the chitosan‐conjugated S. pinnata phytocompounds and S. pinnata leaf extracts was evaluated via DPPH and ABTS assays, and the results revealed that the chitosan‐conjugated S. pinnata phytocompounds exhibited significant scavenging activity, with IC50 values of 18.20 and 33.15 μg/mL, respectively. Chitosan‐conjugated S. pinnata phytocompounds also demonstrated antibacterial activity against four clinically significant infections, with zones of inhibition ranging from 16 ± 0.07, 19 ± 0.10, 17 ± 0.09, and 19 ± 0.11 mm against Escherichia coli (MTCC 452), Salmonella typhi (MTCC 733), Klebsiella pneumonia (MTCC 39), and Pseudomonas aeruginosa (MTCC 1688), respectively. Furthermore, the cytotoxicity of the chitosan‐conjugated S. pinnata phytocompounds was assessed against A549 lung cancer cells, and the results revealed a significant reduction in cell viability (33.85) at higher concentrations of 150 μg/mL. The IC50 values of S. pinnata leaf extract (149.2 mg/mL) and chitosan‐conjugated S. pinnata (126.4 mg/mL) toward A549 lung cancer cells were recorded. Overall, the results of the present study highlight the therapeutic applications of chitosan‐conjugated S. pinnata phytocompounds, particularly in the context of their anticancer and antibacterial activities.
期刊介绍:
Polymers for Advanced Technologies is published in response to recent significant changes in the patterns of materials research and development. Worldwide attention has been focused on the critical importance of materials in the creation of new devices and systems. It is now recognized that materials are often the limiting factor in bringing a new technical concept to fruition and that polymers are often the materials of choice in these demanding applications. A significant portion of the polymer research ongoing in the world is directly or indirectly related to the solution of complex, interdisciplinary problems whose successful resolution is necessary for achievement of broad system objectives.
Polymers for Advanced Technologies is focused to the interest of scientists and engineers from academia and industry who are participating in these new areas of polymer research and development. It is the intent of this journal to impact the polymer related advanced technologies to meet the challenge of the twenty-first century.
Polymers for Advanced Technologies aims at encouraging innovation, invention, imagination and creativity by providing a broad interdisciplinary platform for the presentation of new research and development concepts, theories and results which reflect the changing image and pace of modern polymer science and technology.
Polymers for Advanced Technologies aims at becoming the central organ of the new multi-disciplinary polymer oriented materials science of the highest scientific standards. It will publish original research papers on finished studies; communications limited to five typewritten pages plus three illustrations, containing experimental details; review articles of up to 40 pages; letters to the editor and book reviews. Review articles will normally be published by invitation. The Editor-in-Chief welcomes suggestions for reviews.